| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | CSTL Castle Biosciences INC | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 5,115 | $40.05 | $204,850.64 | -10.0% | - | - | |
| Nov 25, 2025 | DHR Danaher CORP /de/ | Rales Mitchell P | Chairman Of Exec. Committee | Sell | 40,625 | $230.38 | $9,359,066.67 | -2.3% | - | - | |
| Nov 25, 2025 | VCYT Veracyte, INC. | Leite John | Chief Commercial Officer-clia | Sell | 2,808 | $50.00 | $140,400.00 | -3.2% | - | - | |
| Nov 25, 2025 | VCYT Veracyte, INC. | Jones Evan/ Fa | Director | Sell | 1,106 | $50.25 | $55,575.73 | -3.6% | - | - | |
| Nov 25, 2025 | TMO Thermo Fisher Scientific INC. | Shafer Michael D | Executive Vice President | Sell | 10,725 | $600.00 | $6,435,000.00 | -22.3% | - | - | |
| Nov 25, 2025 | NEO Neogenomics INC | Olivo Alicia C | EVP, GC &Business Development | Sell | 20,916 | $12.00 | $250,992.00 | -40.2% | - | - | |
| Nov 25, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 42,392 | $615.52 | $26,093,123.84 | -5.5% | - | - | |
| Nov 25, 2025 | MTD Mettler Toledo International Inc/ | Vadala Shawn | Chief Financial Officer | Sell | 1,000 | $1,511.00 | $1,511,000.00 | -15.9% | - | - | |
| Nov 24, 2025 | WGS Genedx Holdings CORP. | Ruch Joshua | - | Sell | 29,843 | $160.47 | $4,789,033.15 | -4.9% | - | - | |
| Nov 24, 2025 | NTRA Natera, INC. | Botha Roelof | Director | Sell | 29,441 | $236.29 | $6,956,616.90 | -0.6% | - | - | |
| Nov 24, 2025 | MEDP Medpace Holdings, INC. | Burwig Susan E | Exec. VP, Operations | Sell | 20,000 | $609.15 | $12,183,000.00 | -42.1% | - | - | |
| Nov 24, 2025 | FLGT Fulgent Genetics, INC. | Gao Hanlin | Chief Scientific Officer | Sell | 535 | $30.47 | $16,303.06 | - | - | - | |
| Nov 24, 2025 | FLGT Fulgent Genetics, INC. | Xie Jian | President And COO | Sell | 681 | $30.47 | $20,752.11 | -0.2% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.